Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital

• Autor(a) principal: Zornoff, Leonardo Antonio Mamede [UNESP]
• Data de Publicação: 2002
• Outros Autores: Paiva, Sergio Alberto Rupp de [UNESP], Assalin, Vanessa M. [UNESP], Pola, Patrícia M. S. [UNESP], Becker, Luís E. [UNESP], Okoshi, Marina Politi [UNESP], Matsubara, Luiz Shiguero [UNESP], Inoue, Roberto M. T. [UNESP], Spadaro, Joel [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1590/S0066-782X2002000400007; http://hdl.handle.net/11449/11288
• topic: myocardial infarction; mortality; treatment

OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We retrospectively studied 172 patients with acute myocardial infarction, admitted in the intensive care unit from January 1992 to December 1997. RESULTS: Most patients were male (68%), white (97%), and over 60 years old (59%). The main risk factor for coronary atherosclerotic disease was systemic blood hypertension (63%). Among all the variables studied, reperfusion therapy, smoking, hypertension, cardiogenic shock, and age were the predictors of 30-day mortality. Most commonly used medications were: acetylsalicylic acid (71%), nitrates (61%), diuretics (51%), angiotensin-converting enzyme inhibitors (46%), thrombolytic therapy (39%), and beta-blockers (35%). CONCLUSION: The absence of reperfusion therapy, smoking status, hypertension, cardiogenic shock, and advanced age are predictors of 30-day mortality in patients with acute myocardial infarction. In addition, some medications that are undoubtedly beneficial have been under-used after acute myocardial infarction.